FORNI, Flavio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 35.218
EU - Europa 20.264
AS - Asia 15.863
SA - Sud America 2.241
AF - Africa 415
OC - Oceania 47
Continente sconosciuto - Info sul continente non disponibili 27
Totale 74.075
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 34.752
GB - Regno Unito 6.628
SG - Singapore 4.521
CN - Cina 4.472
IT - Italia 4.325
SE - Svezia 3.764
HK - Hong Kong 2.076
BR - Brasile 1.684
VN - Vietnam 1.668
DE - Germania 1.140
TR - Turchia 810
UA - Ucraina 801
FI - Finlandia 735
RU - Federazione Russa 709
FR - Francia 673
KR - Corea 542
IN - India 406
BG - Bulgaria 314
NL - Olanda 201
CA - Canada 193
AR - Argentina 176
BD - Bangladesh 169
MX - Messico 157
JP - Giappone 156
RO - Romania 151
IQ - Iraq 143
ZA - Sudafrica 129
ID - Indonesia 127
IE - Irlanda 126
ES - Italia 112
PL - Polonia 109
PK - Pakistan 98
BE - Belgio 93
AE - Emirati Arabi Uniti 87
EC - Ecuador 87
CO - Colombia 84
CH - Svizzera 66
MY - Malesia 64
TH - Thailandia 60
VE - Venezuela 59
MA - Marocco 57
CL - Cile 56
IR - Iran 50
DZ - Algeria 48
EG - Egitto 46
LT - Lituania 45
PH - Filippine 42
UZ - Uzbekistan 42
SA - Arabia Saudita 40
AU - Australia 39
CZ - Repubblica Ceca 36
IL - Israele 36
PT - Portogallo 36
JO - Giordania 35
NP - Nepal 35
PE - Perù 34
TN - Tunisia 34
PY - Paraguay 30
AT - Austria 28
KE - Kenya 27
TW - Taiwan 26
AZ - Azerbaigian 25
GR - Grecia 23
EU - Europa 20
KZ - Kazakistan 20
JM - Giamaica 19
SN - Senegal 19
DO - Repubblica Dominicana 17
ET - Etiopia 17
MD - Moldavia 17
BO - Bolivia 16
DK - Danimarca 16
AL - Albania 14
UY - Uruguay 14
LB - Libano 13
OM - Oman 13
RS - Serbia 12
TT - Trinidad e Tobago 12
BY - Bielorussia 11
CR - Costa Rica 11
HU - Ungheria 11
LV - Lettonia 10
NO - Norvegia 10
PA - Panama 10
KG - Kirghizistan 9
EE - Estonia 8
GT - Guatemala 8
HR - Croazia 8
NZ - Nuova Zelanda 8
BH - Bahrain 7
CY - Cipro 7
HN - Honduras 7
PS - Palestinian Territory 7
SI - Slovenia 7
AM - Armenia 6
AO - Angola 6
KH - Cambogia 6
LK - Sri Lanka 6
LU - Lussemburgo 6
MN - Mongolia 6
Totale 73.951
Salva come PNG Salva come JPEG
Città #
Southend 5.220
Santa Clara 3.350
Ashburn 3.038
Singapore 2.856
Fairfield 2.618
Chandler 2.172
Hong Kong 2.039
Woodbridge 1.903
Stockholm 1.816
Jacksonville 1.618
Hefei 1.443
Houston 1.318
Chicago 1.253
Dearborn 1.215
Wilmington 1.107
Seattle 1.068
Nyköping 1.060
San Jose 1.052
Ann Arbor 1.049
Cambridge 880
Beijing 878
Los Angeles 736
London 735
Ho Chi Minh City 542
Modena 485
Izmir 465
Seoul 462
Helsinki 441
The Dalles 435
Council Bluffs 401
Hanoi 397
Salt Lake City 336
Princeton 324
New York 312
Sofia 301
Eugene 275
Milan 262
Des Moines 247
San Diego 237
Lauterbourg 231
Dallas 226
Rome 201
Buffalo 200
Moscow 182
Redwood City 180
Shanghai 153
São Paulo 147
Bremen 146
Tampa 142
Elk Grove Village 135
Orem 133
Munich 118
Tokyo 117
Dublin 105
Fremont 104
Columbus 98
Frankfurt am Main 94
Boardman 93
Bologna 93
Chennai 86
Brussels 80
Naples 78
Falls Church 76
Guangzhou 76
Lancaster 75
Phoenix 73
Jakarta 70
Da Nang 69
Sterling 65
Haiphong 62
Johannesburg 62
Warsaw 61
Miami 57
Parma 56
Norwalk 54
Brooklyn 52
Washington 52
Atlanta 51
Baghdad 50
Denver 50
Florence 50
Como 49
Nanjing 48
Dulles 47
Amsterdam 46
Turin 46
Kunming 45
Montreal 43
Rio de Janeiro 43
Toronto 43
Detroit 42
Reggio Emilia 42
Belo Horizonte 40
Bari 39
Mexico City 39
Mumbai 39
Napoli 39
Redondo Beach 38
Quito 37
New Delhi 36
Totale 51.450
Salva come PNG Salva come JPEG
Nome #
A novel phytocannabinoid isolated from Cannabis sativa L. with an in vivo cannabimimetic activity higher than Δ9-tetrahydrocannabinol: Δ9-Tetrahydrocannabiphorol 2.290
AFM/TEM complementary structural analysis of surface-functionalized nanoparticles 571
Nanovettori lipidici e polimerici per la somministrazione sito-specifica di farmaci antitumorali 501
Can leptin-derived sequence-modified nanoparticles be suitable tools for brain delivery? 487
Cristallinità ed equivalenza nel cloramfenicolo palmitato 471
Targeting the Central Nervous System: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123 465
Nanoimaging: photophysical and pharmaceutical characterization of poly-lactide-co-glycolide nanoparticles engineered with quantum dots 456
Flow cytometry and live confocal analysis for the evaluation of the uptake and intracellular distribution of FITC-ODN into HaCaT cells 448
Analysis of cannabinoids in commercial hemp seed oil and decarboxylation kinetics studies of cannabidiolic acid (CBDA) 448
Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments 433
Development of a simple and sensitive liquid chromatography triple quadrupole mass spectrometry (LC–MS/MS) method for the determination of cannabidiol (CBD), Δ9-tetrahydrocannabinol (THC) and its metabolites in rat whole blood after oral administration of a single high dose of CBD 422
Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug release 419
Cationic liposomes for gene transfection 417
NUTRASCIENCE s.r.l. 417
AFM, ESEM, TEM and CLSM in liposomal characterization: a comparative study 414
NANOPARTICELLE IBRIDE PLGA/DOPE: STUDI DI TRANSFEZIONE, ESCAPE ENDOSOMIALE E TRAFFICKING CELLULARE 411
Nanoparticulate drug carriers based on hybrid poly(D,L-lactide-co-glycolide)-dendron structures 410
Nanotechnology and Alzheimer’s disease: What has been done and what to do’ 409
NIR-labeled nanoparticles engineered for brain targeting: in vivo optical imaging application and fluorescent microscopy evidences. 409
Use of Polylactide-Co-Glycolide-Nanoparticles for Lysosomal Delivery of a Therapeutic Enzyme in Glycogenosis Type II Fibroblasts 398
Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution 393
Poly (D,L-lactide-co-glycolide) nanoparticles loaded with Cerebrolysin display neuroprotective activity in a rat model of closed head injury 392
Chemico-physical investigation of tenofovir loaded polymeric nanoparticles 392
Apoferritin nanocage as streptomycin drug reservoir: Technological optimization of a new drug delivery system 385
PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting 384
Collagen modified based membranes for tissue engineering: influence of type and molecular weight of GAGs on cell proliferation 379
Peptide-derivatized biodegradable nanoparticles able to cross the blood-brain barrier 379
Sialic Acid as a potential approach for the protection and targeting of nanocarriers 371
Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transport 364
AFM phase imaging of soft-hydrated samples: A versatile tool to complete the chemical-physical study of liposomes 363
Analysis of impurities of cannabidiol from hemp. Isolation, characterization and synthesis of cannabidibutol, the novel cannabidiol butyl analog 361
A Nanoparticle-based approach for drug delivery to the brain in Lysosomal Storage Disorders 359
Polymeric nanoparticles for the drug delivery to the central nervous system 359
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles 359
Distribution of drugs in polymers loaded by swelling 355
Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution 355
Current Strategies for the Delivery of Therapeutic Proteins and Enzymes to Treat Brain Disorders 352
Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo 351
Diffusione di derivati dell\'acido benzoico attraverso membrane lipidiche in presenza di Tween 80 346
Protein corona and nanoparticles: How can we investigate on? 345
Flow Cytometry and live confocal analysis in the evaluation of uptake and intracellular distribution of FITC-ODN into HaCaT cells 344
Complessazione di SiRNA anti Blimp-1/PRDM con liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di PEL 344
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 342
Microwave-treated gelatin microspheres as drug delivery system 341
Protein cage nanostructure as drug delivery system: magnifying glass on apoferritin 340
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 339
Nanoparticle transport across the blood brain barrier 338
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes 338
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma 336
The loading of labeled antibody engineered nanoparticles with Indinavir increases its in vitro efficacy against Cryptosporidium parvum 333
The grinding of the polymorphic forms of chloramphenicol stearic ester in the presence of colloidal silica 325
Biodisponibilità e bioequivalenza in compresse commerciali di nitrofurantoina 325
AFM and TEM characterization of siRNAs lipoplexes: a combinatory tools to predict the efficacy of complexation 325
NANOPARTICELLE POLIMERICHE PER LA VEICOLAZIONE DI MACROMOLECOLE PROTEICHE: STUDI PRELIMINARI DI CARATTERIZZAZIONE TECNOLOGICA 325
Isolation of a High-Affinity Cannabinoid for the Human CB1 Receptor from a Medicinal Cannabis sativa Variety: Δ9-Tetrahydrocannabutol, the Butyl Homologue of Δ9-Tetrahydrocannabinol 325
Qualitative and semiquantitative analysis of the protein coronas associated to different functionalized nanoparticles 323
Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery 322
Conjugated poly(D,L-lactide-co-glycolide) for the preparation of in vivo detectable nanoparticles 322
A theoretical model for the calculation of the drug distribution profile in matrices of different shape to achieve the desired drug release kinetics 321
How does “Protein Corona” Affect the In vivo Efficiency of Polymeric Nanoparticles? State of Art 320
Peptide-engineered polylactide-co-glycolide (PLGA) nanoparticles for brain delivery of drugs: in vivo experiments and proof of concept 318
Dotap/Udca vesicles: novel approach in oligonucleotide delivery 318
Investigation on Mechanisms of Glycopeptide Nanoparticles for Drug Delivery across the Blood-Brain Barrier 317
Development and characterization of biodegradable nanospheres as delivery systems of anti-ischemic adenosine derivatives 316
Cannabinoid profiling of hemp seed oil by liquid chromatography coupled to high-resolution mass spectrometry 316
Nanoparticles engineered with rituximab and loaded with Nutlin-3 show promising therapeutic activity in B-leukemic xenografts. 311
Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach 311
Liposome-oligonucleotides interaction for in vitro uptake by COSI and HaCaT cells 310
Brain targeting by engineered nanoparticles: in vivo and in vitro evidences 310
Glioblastoma: State of the Art of Treatments and Applications of Polymeric and Lipidic Nanomedicines 305
Development of novel Zn2+ loaded nanoparticles designed for cell-type targeted drug release in CNS neurons: in vitro evidences. 303
Brain-targeted polymeric nanoparticles: In vivo evidence of different routes of administration in rodents 302
NANOPARTICELLE POLIMERICHE PER IL DIREZIONAMENTO CEREBRALE: DELIVERY DI ZINCO E STUDI PRELIMINARI IN VITRO SU CELLULE NEURONALI 301
PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept Study 301
Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice 300
Untargeted rat brain metabolomics after oral administration of a single high dose of cannabidiol 300
Chemical and spectroscopic characterization data of ‘cannabidibutol’, a novel cannabidiol butyl analog 300
PLGA Nanoparticles Loaded Cerebrolysin: Studies on Their Preparation and Investigation of the Effect of Storage and Serum Stability with Reference to Traumatic Brain Injury 298
Targeted polymeric nanoparticles for brain delivery of high molecular weight molecules in lysosomal storage disorders 298
Potential Use of Nanomedicine for Drug Delivery Across the Blood-Brain Barrier in Healthy and Diseased Brain 298
Acidi colici nella preparazione di liposomi cationici per la transfezione in cellule HaCaT 297
Nanoparticles for brain delivery of drugs: in vivo experiments andmechanism of BBB crossing 296
Functionalization of liposomes: microscopical methods for preformulative screening 296
Identification of a new cannabidiol n-hexyl homolog in a medicinal cannabis variety with an antinociceptive activity in mice: cannabidihexol 296
Colloidal systems for CNS drug delivery 295
NANOMEDICINE IN NEUROSCIENCE: THE POTENTIAL OF TARGETED NANOPARTICLES IN NEURODEGENERATIVE DISORDERS 292
Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma 291
Biodegradable device applied in flatfoot surgery: Comparative studies between clinical and technological aspects of removed screws 290
Pitfalls in the analysis of phytocannabinoids in cannabis inflorescence 290
Applicazione delle tecniche microscopiche, spettroscopiche e calorimetriche nella caratterizzazione di nanoparticelle funzionalizzate 289
Atomic force microscopy and photon correlation spectroscopy: Two techniques for rapid characterization of liposomes 287
AN INTERPRETATIVE ANALYSIS OF THE EFFECT OF THE SURFACTANTS USED FOR THE PREPARATION OF POLYALKYLCYANOACRYLATE NANOPARTICLES ON THE RELEASE PROCESS 287
Pseudomorfosi nel cloramfenicolo stearato e palmitato in relazione alla disponibilità 285
EXPLOITING THE VERSATILITY OF CHOLESTEROL IN NANOPARTICLES FORMULATION 284
Activitè enzymatique de la pancréatine de formes pharmaceutiques: une nouvelle méthode d'évaluation 283
A solution and solid state study on 2-hydroxypropyl-beta-cyclodextrin complexation with hyodeoxycholic acid 281
Glycopeptide-decorated nanoparticles as drug carriers for CNS: effects of surface coverage and carbohydrate type 280
2-HYDROXYPROPYL-BETA-CYCLODEXTRIN COMPLEXATION WITH URSODEOXYCHOLIC ACID 278
Preformulative and formulative studies on inclusion complexes between cyclodextrins and ursodeoxycholic acid 276
Papaverine hydrochloride release from ethyl cellulose-walled microcapsules 276
Totale 36.550
Salva come PNG Salva come JPEG
Categoria #
all - tutte 259.148
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 259.148
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.860 0 0 0 0 0 0 0 0 0 1.076 442 342
2021/20225.275 221 631 486 430 173 261 274 296 604 387 871 641
2022/20236.271 749 683 534 609 764 980 160 525 673 96 225 273
2023/20243.890 185 227 226 295 816 391 468 527 138 118 173 326
2024/202512.486 647 183 264 943 2.567 1.738 895 819 1.177 476 1.302 1.475
2025/202622.127 1.437 785 1.782 2.776 4.171 1.590 2.383 1.060 4.114 2.029 0 0
Totale 74.516